Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...
PBFT02 administration resulted in improvements in two disease progression biomarkers, as compared to natural history, reducing brain atrophy and ...
A landmark trial presented at ESCMID Global 2026 shows that improving oral hygiene for hospital patients can reduce the risk ...
Data from randomized controlled trials shows that most patients’ moods actually improve when treated for obesity with GLP-1 ...
Randomized Controlled Trials (RCTs) are the gold standard of medical research as random assignment approach helps eliminate bias and yields the most reliable evidence on whether a treatment truly ...
Carica papaya leaf extract (CPLE) versus placebo to improve chemotherapy induced thrombocytopenia (CIT): Results of a phase III triple blinded, randomized placebo controlled trial (PACT study).
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR–Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer Study ...
Sunrise Group, a pioneer in medical device innovation and sleep care, today announced results from the SUNSAS clinical study, now published in The Lancet Regional Health – Europe, a leading ...
PuraPly® AM is a patent-protected product that is differentiated among all skin substitutes by combining a native, cross-linked collagen matrix with polyhexamethylene biguanide (PHMB) antimicrobial to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results